Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
Biologics : Targets & Therapy|August 27, 2009
Efalizumab in the treatment of psoriasisWolf-Henning BoehnckeRheumatic Diseases Clinics of North America|October 18, 2015
Etiology and Pathogenesis of PsoriasisWolf-Henning BoehnckeThe Journal of Rheumatology|June 3, 2014
GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoringWolf-Henning BoehnckeThe Journal of Rheumatology|February 3, 2012
Epidemiology and potential pathomechanisms of cardiovascular comorbidities in psoriasis: a report from the GRAPPA 2010 annual meetingWolf-Henning BoehnckeEuropean Journal of Dermatology : EJD|July 13, 2004
The alpha-defensins HNP-1 and HNP-2 are dominant self-peptides presented by HLA class-II molecules in lesional psoriatic skinWolf-Henning BoehnckeFrontiers in Immunology|April 21, 2018
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and ConsequencesWolf-Henning BoehnckeActa Dermato-Venereologica|March 2, 2016
Psoriasis and Psoriatic Arthritis: Flip Sides of the Coin?Wolf-Henning BoehnckeJournal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 26, 2011
Clinical long-term studies: data collection and assessmentWolf-Henning BoehnckeDer Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 30, 2021
[Psoriatic arthritis: important aspects for the dermatological practice]Wolf-Henning BoehnckePageof 21